Johnson & Johnson to Acquire Intra-Cellular Therapies
Johnson & Johnson to Buy Intra-Cellular Therapies for $14.6 Billion Johnson & Johnson said it would purchase drugmaker Intra-Cellular Therapies for $14.6…
Johnson & Johnson to Buy Intra-Cellular Therapies for $14.6 Billion Johnson & Johnson said it would purchase drugmaker Intra-Cellular Therapies for $14.6…
Gilead Sciences Enters Partnership with LEO Pharma to Develop Inflammatory Disease Treatments Gilead Sciences, a biopharmaceutical company, has entered into a partnership…